15 Quotes by Michael Perdue

The (more recent) studies that have been done, one of the reasons frankly that I think they haven't been followed up on, is they haven't found many positives. You don't get too excited about all negative serology (blood work).

It's a little concerning because the virus is still trying new things in its evolution.

It's very important to do this kind surveillance so that we know what's going on. And we're hopeful, since there are some clear differences, that these viruses will be made available to other investigators to do further analysis.

Clearly, we're not seeing widespread classical influenza infections with this virus or we would have picked it up by now. I think the case fatality rate probably is pretty significant given the data that we have.

The evidence for widespread asymptomatic infections is just not there. The (more recent) studies that have been done, one of the reasons frankly that I think they haven't been followed up on, is they haven't found many positives. You don't get too excited about all negative serology (blood work).

The evidence for widespread asymptomatic infections is just not there.